S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
All the trading advice you’ve ever received boils down to this (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
All the trading advice you’ve ever received boils down to this (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
All the trading advice you’ve ever received boils down to this (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
A 'soft landing' or a recession? How each one might affect America's households and businesses
Closing prices for crude oil, gold and other commodities
All the trading advice you’ve ever received boils down to this (Ad)
How major US stock indexes fared Friday, 12/8/2023
MarketBeat Week in Review – 12/4 - 12/8
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
Amazon asks federal judge to dismiss the FTC's antitrust lawsuit against the company

CASI Pharmaceuticals (CASI) News Today

$7.04
-0.46 (-6.13%)
(As of 12/8/2023 ET)
Compare
Today's Range
$6.10
$8.36
50-Day Range
$2.62
$7.50
52-Week Range
$1.45
$8.36
Volume
268,287 shs
Average Volume
N/A
Market Capitalization
$93.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
SourceHeadline
MarketBeat logoCASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com
americanbankingnews.com - December 7 at 1:22 AM
markets.businessinsider.com logoHC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know
markets.businessinsider.com - November 15 at 1:58 PM
markets.businessinsider.com logoCASI Pharmaceuticals Posts Narrower Loss In Q3
markets.businessinsider.com - November 14 at 10:21 AM
msn.com logoCASI Pharmaceuticals GAAP EPS of -$0.35, revenue of $8.84M
msn.com - November 14 at 10:21 AM
finance.yahoo.com logoCASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
finance.yahoo.com - November 14 at 10:21 AM
markets.businessinsider.com logoCASI : Juventas' CNCT 19 Approved In China For R/R B-cell Acute Lymphoblastic Leukemia Treatment
markets.businessinsider.com - November 8 at 8:33 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for CASI Pharmaceuticals (CASI)
markets.businessinsider.com - August 14 at 9:43 AM
markets.businessinsider.com logoCASI Pharmaceuticals, Inc. Q2 Loss Widens
markets.businessinsider.com - August 11 at 6:11 PM
msn.com logoCASI Pharmaceuticals GAAP EPS of -$0.77, revenue of $9.82M
msn.com - August 11 at 6:11 PM
finance.yahoo.com logoCASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
finance.yahoo.com - August 11 at 6:11 PM
msn.com logoIonis Pharmaceuticals (IONS) Q2 Earnings and Revenues Surpass Estimates (Revised)
msn.com - August 10 at 5:10 PM
msn.com logoProPhase Labs, Inc. (PRPH) Reports Q2 Loss, Lags Revenue Estimates
msn.com - August 10 at 11:06 AM
finance.yahoo.com logoMundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals
finance.yahoo.com - August 1 at 7:28 PM
finance.yahoo.com logoCleave Therapeutics Announces Acquisition of Clinical and Preclinical Assets
finance.yahoo.com - July 20 at 8:35 AM
finance.yahoo.com logoCASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339
finance.yahoo.com - July 20 at 8:35 AM
finance.yahoo.com logoSwitch Therapeutics Appoints Douglas Fambrough, Ph.D., to Board of Directors
finance.yahoo.com - July 10 at 8:11 AM
finance.yahoo.com logoCASI - CASI Pharmaceuticals, Inc.
finance.yahoo.com - June 28 at 8:27 PM
finance.yahoo.com logoWe Think CASI Pharmaceuticals (NASDAQ:CASI) Needs To Drive Business Growth Carefully
finance.yahoo.com - May 28 at 10:37 AM
finanznachrichten.de logoCASI Pharmaceuticals, Inc. Announces First Quarter 2023 Financial Results
finanznachrichten.de - May 17 at 8:52 AM
finance.yahoo.com logoCASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
finance.yahoo.com - May 17 at 8:52 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Cytosorbents (CTSO)
markets.businessinsider.com - May 3 at 7:26 AM
msn.com logoCASI Pharmaceuticals GAAP EPS of -$3.01 misses by $2.64, revenue of $43.12M beats by $32.31M
msn.com - April 26 at 2:43 PM
finance.yahoo.com logoCASI Pharmaceuticals Files Annual Report on Form 20-F for Fiscal Year 2022
finance.yahoo.com - April 26 at 2:43 PM
finance.yahoo.com logoCASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2022 FINANCIAL RESULTS
finance.yahoo.com - April 26 at 9:42 AM
finance.yahoo.com logoImproved Revenues Required Before CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Stock's 114% Jump Looks Justified
finance.yahoo.com - April 17 at 7:37 AM
benzinga.com logoWill CASI Pharmaceuticals Inc (CASI) Outperform the Rest of the Stocks in the Healthcare Sector?
benzinga.com - April 12 at 10:40 PM
marketwatch.com logoLisinopril Market Top Players and Forecast till 2031
marketwatch.com - March 23 at 9:16 AM
finanznachrichten.de logoCASI Pharmaceuticals, Inc. Completes Redomiciliation Merger
finanznachrichten.de - March 22 at 7:48 AM
marketwatch.com logoHypoxia Inducible Factor 1 Alpha Inhibitor Market Size 2023 Research Report by Growth Rate Analysis and Forecast till 2027
marketwatch.com - March 17 at 7:51 PM
marketwatch.com logoTumor Necrosis Factor Inhibitors Market Size 2023 - 2030: About its Application, Qrganization Size, Sales Volume, and Regional Outlook
marketwatch.com - March 13 at 7:21 AM
msn.com logoFoghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Lags Revenue Estimates
msn.com - March 9 at 5:57 PM
markets.businessinsider.com logoBTIG Reaffirms Their Hold Rating on MEI Pharma (MEIP)
markets.businessinsider.com - February 14 at 7:10 AM
finance.yahoo.com logoA CASI Pharmaceuticals, Inc. (NASDAQ:CASI) insider increased their holdings by 16% last year
finance.yahoo.com - February 6 at 10:25 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM)
markets.businessinsider.com - January 30 at 8:48 AM
marketwatch.com logoMarginal Zone B-cell Lymphoma Drugs Market Size, Outlook, Share, Prominent Players, Growth, and Forecast 2029
marketwatch.com - January 18 at 9:50 AM
finance.yahoo.com logoCASI PHARMACEUTICALS AND CLEAVE THERAPEUTICS ANNOUNCE CLINICAL TRIAL APPLICATION APPROVAL FOR CB-5339 IN PATIENTS WITH MULTIPLE MYELOMA IN CHINA
finance.yahoo.com - January 6 at 9:20 AM
finance.yahoo.com logoCasi Pharmaceuticals to run clinical trial for multiple myeloma drug in China
finance.yahoo.com - January 6 at 9:20 AM
marketwatch.com logoAnalysis of Ibritumomab Tiuxetan Market for the Period 2023 to 2028 : Development, Growth and Key Factors
marketwatch.com - January 5 at 7:57 AM
msn.com logoChinese pharmas and biotechs risk of delisting averted as US regulators review audits
msn.com - December 16 at 6:42 PM
finance.yahoo.com logoCASI PHARMACEUTICALS' PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION
finance.yahoo.com - December 15 at 7:39 AM
finance.yahoo.com logoCASI Pharmaceuticals Third Quarter 2022 Earnings: Beats Expectations
finance.yahoo.com - November 17 at 6:50 AM
finance.yahoo.com logoCASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS
finance.yahoo.com - November 14 at 11:05 AM
finance.yahoo.com logoCASI Pharmaceuticals, Inc. (CASI) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 14 at 11:05 AM
nasdaq.com logoScynexis (SCYX) Reports Q3 Loss, Misses Revenue Estimates
nasdaq.com - November 9 at 11:30 AM
forbes.com logoCasi Pharmaceuticals
forbes.com - October 7 at 3:52 PM
marketwatch.com logoCASI Pharmaceuticals Exits Juventas Biotechnology Investment
marketwatch.com - September 23 at 8:42 AM
finance.yahoo.com logoCASI PHARMACEUTICALS ANNOUNCES EXIT OF JUVENTAS INVESTMENT TO STRENGTHEN BALANCE SHEET
finance.yahoo.com - September 23 at 8:42 AM
msn.com logoCASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
msn.com - September 9 at 10:50 AM
nasdaq.com logoWednesday 9/7 Insider Buying Report: JELD, CASI
nasdaq.com - September 7 at 6:02 PM
finance.yahoo.com logoCASI PHARMACEUTICALS AND BIOINVENT ANNOUNCE DOSING OF FIRST PATIENT IN BI-1206 PHASE 1 CLINICAL TRIAL FOR THE TREATMENT OF RELAPSED/REFRACTORY NON-HODGKIN'S LYMPHOMA IN CHINA
finance.yahoo.com - September 7 at 8:00 AM
Get CASI Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CASI and its competitors with MarketBeat's FREE daily newsletter.



CASI Media Mentions By Week

CASI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CASI
News Sentiment

0.25

0.51

Average
Medical
News Sentiment

CASI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CASI Articles
This Week

1

0

CASI Articles
Average Week

Get CASI Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CASI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CASI) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -